1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key Market
Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market Drivers,
Challenges, Trends
4. Voice of Customer
5.
Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Region
5.8. Clinical Trials Heat
Map
6.
Global Narcolepsy Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Type (Type 1, Type 2, Others)
6.2.2. By Diagnosis (Polysomnogram, Multiple
Sleep Latency Test, Others)
6.2.3. By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others)
6.2.4. By End User (Hospitals, Clinics, Retail Pharmacies, Others)
6.2.5. By Company (2022)
6.3. Product Map
5.3.1 By Type
5.3.2 By Diagnosis
5.3.3 By Treatment
5.3.4 By End User
7.
North America Narcolepsy Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Type (Type 1, Type 2, Others)
7.2.2. By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others)
7.2.3. By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others)
7.2.4. By End User (Hospitals, Clinics, Retail Pharmacies, Others)
7.2.5. By Country
7.3. North America:
Country Analysis
7.3.1. United States Narcolepsy
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Diagnosis
7.3.1.2.3.
By Treatment
7.3.1.2.4.
By End User
7.3.2. Canada Narcolepsy
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Diagnosis
7.3.2.2.3.
By Treatment
7.3.2.2.4.
By End User
7.3.3. Mexico Narcolepsy
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Diagnosis
7.3.3.2.3.
By Treatment
7.3.3.2.4.
By End User
8.
Europe Narcolepsy Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Treatment Type (Chest Pain, Headache, Fever,
Pneumonia, Hypertension, Fatigue, Sleep Problems)
8.2.2. By Type (Type 1, Type 2, Others)
8.2.3. By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others)
8.2.4. By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others)
8.2.5. By End User (Hospitals, Clinics, Retail Pharmacies, Others)
8.2.6. By Country
8.3. Europe: Country
Analysis
8.3.1. France Narcolepsy
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Diagnosis
8.3.1.2.3.
By Treatment
8.3.1.2.4.
By End User
8.3.2. Germany Narcolepsy
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Diagnosis
8.3.2.2.3.
By Treatment
8.3.2.2.4.
By End User
8.3.3. United Kingdom Narcolepsy
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Diagnosis
8.3.3.2.3.
By Treatment
8.3.3.2.4.
By End User
8.3.4. Italy Narcolepsy
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Diagnosis
8.3.4.2.3.
By Treatment
8.3.4.2.4.
By End User
8.3.5. Spain Narcolepsy
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Diagnosis
8.3.5.2.3.
By Treatment
8.3.5.2.4.
By End User
9.
Asia-Pacific Narcolepsy Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Type (Type 1, Type 2, Others)
9.2.2. By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others)
9.2.3. By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others)
9.2.4. By End User (Hospitals, Clinics, Retail Pharmacies, Others)
9.2.5. By Country
9.3. Asia-Pacific:
Country Analysis
9.3.1. China Narcolepsy
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Diagnosis
9.3.1.2.3.
By Treatment
9.3.1.2.4.
By End User
9.3.2. India Narcolepsy
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Diagnosis
9.3.2.2.3.
By Treatment
9.3.2.2.4.
By End User
9.3.3. Japan Narcolepsy
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Diagnosis
9.3.3.2.3.
By Treatment
9.3.3.2.4.
By End User
9.3.4. South Korea Narcolepsy
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Diagnosis
9.3.4.2.3.
By Treatment
9.3.4.2.4.
By End User
9.3.5. Australia Narcolepsy
Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Diagnosis
9.3.5.2.3.
By Treatment
9.3.5.2.4.
By End User
10.
South America Narcolepsy Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Type (Type 1, Type 2, Others)
10.2.2. By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others)
10.2.3. By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others)
10.2.4. By End User (Hospitals, Clinics, Retail Pharmacies, Others)
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Narcolepsy
Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Diagnosis
10.3.1.2.3.
By Treatment
10.3.1.2.4.
By End User
10.3.2. Argentina Narcolepsy
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.